Perbandingan biaya terapi hemodialisis dengan peritoneal dialisis di Asia: Narrative review
DOI:
10.29303/sjp.v4i2.330Downloads
Abstract
The high prevalence of Chronic Kidney Disease (CKD) patients increases the demand for dialysis therapy. Studies comparing dialysis modality therapies undergone by CKD patients in the Asian region are still limited. The research objective is to compare the costs of Hemodialysis (HD) and Peritoneal Dialysis (PD) therapies in Asian countries. The review of 4 Asian regions indicates that patients undergoing HD therapy have a higher financial burden than PD therapy. The main costs affecting the high expenses of HD therapy come from the remuneration of healthcare professionals specialized in assisting patients, including doctors, nurses, and technicians. Productivity loss and transportation costs also contribute to HD therapy's higher costs than PD therapy. However, in the Western Asian region, PD therapy costs more than Hemodialysis therapy. PD therapy costs more due to additional direct medical expenses such as filters, bicarbonate cartridges, tubes, acid dialysate, and pyrogen filters.
Keywords:
cost, hemodialysis, peritoneal dialysis, asiaReferences
Aoun, M., Helou, E., Sleilaty, G., Zeenny, R. M., & Chelala, D. (2022). Cost of illness of chronic kidney disease in Lebanon : from the societal and third ‑ party payer perspectives. BMC Health Services Research, 1–11. https://doi.org/10.1186/s12913-022-07936-0
Assanatham, M., Pattanaprateep, O., Chuasuwan, A., & Vareesangthip, K. (2022). Economic evaluation of peritoneal dialysis and hemodialysis in Thai population with End ‑ stage Kidney Disease. BMC Health Services Research, 1–10. https://doi.org/10.1186/s12913-022-08827-0
Bayani, D. B. S., Joy, B., Geovin, Q. A., Uy, D. C., Joy, M., Romina, S. T., Arakama, S. D. M. I., Lamban, A. B., Leon, D. De, Eleanor, G., Cynthia, A., & Yot, L. (2021). Filtering for the best policy : An economic evaluation of policy options for kidney replacement coverage in the Philippines. October 2020, 170–177. https://doi.org/10.1111/nep.13830
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Cullis, B., Htay, H., Jha, V., Makusidi, M. A., McCulloch, M., Shah, N., Wainstein, M., & Johnson, D. W. (2022). Epidemiology of peritoneal dialysis outcomes. Nature Reviews Nephrology, 18(12), 779–793. https://doi.org/10.1038/s41581-022-00623-7
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., Ahmadian, E., Al-Aly, Z., Alipour, V., Almasi-Hashiani, A., Al-Raddadi, R. M., Alvis-Guzman, N., Amini, S., Andrei, T., Andrei, C. L., … Murray, C. J. L. (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 395(10225), 709–733. https://doi.org/10.1016/S0140-6736(20)30045-3
El Shamy, O. (2022). Does Temporary Hemodialysis Before Peritoneal Dialysis Initiation Affect Patient Outcomes? Kidney International Reports, 7(8), 1734–1736. https://doi.org/10.1016/j.ekir.2022.05.039
Gao, D., Jing, S., Wu, J., & Wu, G. (2018). Economic burden and medical insurance impact of the different dialysis for end-stage renal diseases. Iranian Journal of Public Health, 47(11), 1675–1680.
Gorham, G., Howard, K., Zhao, Y., Ahmed, A. M. S., Lawton, P. D., Sajiv, C., Majoni, S. W., Wood, P., Conlon, T., Signal, S., Robinson, S. L., Brown, S., & Cass, A. (2019). Cost of dialysis therapies in rural and remote Australia - A micro-costing analysis. BMC Nephrology, 20(1), 1–11. https://doi.org/10.1186/s12882-019-1421-z
Jeloka, T. K., Upase, S., & Chitikeshi, S. (2012). Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patients. 22(1), 39–42. https://doi.org/10.4103/0971-4065.83739
Karopadi, A. N., Mason, G., Rettore, E., & Ronco, C. (2013). Cost of peritoneal dialysis and haemodialysis across the world. Nephrology Dialysis Transplantation, 28(10), 2553–2569. https://doi.org/10.1093/ndt/gft214
Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements, 12(1), 7–11. https://doi.org/10.1016/j.kisu.2021.11.003
Liyanage, T., Toyama, T., Hockham, C., Ninomiya, T., Perkovic, V., Woodward, M., Fukagawa, M., Matsushita, K.,
Praditpornsilpa, K., Hooi, L. S., Iseki, K., Lin, M. Y., Stirnadel-Farrant, H. A., Jha, V., & Jun, M. (2022). Prevalence of chronic kidney disease in Asia: A systematic review and analysis. BMJ Global Health, 7(1), 1–9. https://doi.org/10.1136/bmjgh-2021-007525
Mushi, L., Marschall, P., & Fleßa, S. (2015). The cost of dialysis in low and middle-income countries: A systematic review. BMC Health Services Research, 15(1), 1–10. https://doi.org/10.1186/s12913-015-1166-8
Novelia, E., Nugraha, R. R., & Thabrany, H. (2017). Cost Effectiveness Analysis Between Hemodialysis and Peritoneal Dialysis. Jurnal Ekonomi Kesehatan Indonesia, 1(3). https://doi.org/10.7454/eki.v1i3.1776
Putri, S., Nugraha, R. R., Pujiyanti, E., Thabrany, H., Hasnur, H., & Istanti, N. D. (2022). Supporting dialysis policy for end stage renal disease ( ESRD ) in Indonesia : an updated cost ‑ effectiveness model. BMC Research Notes, 1–6. https://doi.org/10.1186/s13104-022-06252-4
Rees, C. E., Monrouxe, L. V., O’Brien, B. C., Gordon, L. J., & Palermo, C. (2023). Foundations of Health Professions Education Research. John Wiley & Sons.
Surendra, N. K., Manaf, M. R. A., Seong, H. L., Bavanandan, S., Nor, F. S. M., Khan, S. S. F., Meng, O. L., & Gafor, A. H. A. (2018). The cost of dialysis in Malaysia: Haemodialysis and continuous ambulatory peritoneal dialysis. Malaysian Journal of Public Health Medicine, 18(2), 70–81.
Wong, C.K.H., Chen, J., Fung, S.K.S. et al. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy. BMC Nephrol 21, 42 (2020). https://doi.org/10.1186/s12882-020-1708-0
Yang, F., Lau, T., & Luo, N. (2016). Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology (Carlton), 21(8), 669–677. https://doi.org/10.1111/nep.12668
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Sasambo Journal of Pharmacy (SJP), agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional. This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Sasambo Journal of Pharmacy
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
